GSS genetic signatures limited

Ann: Appendix 4D and Half Year Financial Statements, page-3

  1. 212 Posts.
    lightbulb Created with Sketch. 28
    I was holding LBT when it got FDA approval and the SP spiked 5-fold in a few days - v exciting. Admittedly, it mainly due to hype as the company didn't have recurring sales income at the time (and still doesn't). GSS is different in that it already has sales revenue growing nicely and plenty of cash. It feels a less risky stock, but still with plenty of upside as molecular diagnostics is such a growing field and FDA approval is still ahead. I'm not sure what sort of time frame's involved, often a share price will rise in anticipation of approval. I get the impression its maybe 1-2 years.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
36.5¢
Change
-0.015(3.95%)
Mkt cap ! $82.90M
Open High Low Value Volume
37.0¢ 37.0¢ 36.5¢ $7.667K 20.72K

Buyers (Bids)

No. Vol. Price($)
5 16957 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 4419 1
View Market Depth
Last trade - 13.27pm 10/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.